Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · August 27, 2023

Efficacy and Safety of Oral Minocycline in the Treatment of Patients With Retinitis Pigmentosa–Associated Cystoid Macular Edema

Graefe's Archive for Clinical and Experimental Ophthalmology


Additional Info

Graefe's Archive for Clinical and Experimental Ophthalmology
Oral minocycline for the treatment of retinitis pigmentosa-associated cystoid macular edema: results of a phase I/II clinical trial
Graefes Arch. Clin. Exp. Ophthalmol 2023 Aug 01;261(8)2209-2220, AD Dave, KG Chen, TT Chiang, J Singaravelu, JA Alvarez, WT Wong, CA Cukras

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading